Biological immunopotentiator composition for treating cancers
A technology of biological immunity and enhancer, applied in the direction of drug combination, resistance to vector-borne diseases, medical raw materials derived from bacteria, etc., can solve problems such as unbearable for patients, high treatment costs, and difficult to promote
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0040] According to inactivated Salmonella typhi 500 million-15 billion, inactivated pertussis 1 billion-10 billion, diphtheria toxoid 0-2000Lf or tetanus toxoid 0-500Lf or Staphylococcus aureus enterotoxin C 0-5000ng , the ratio of polysaccharide 0-5g to prepare active ingredients, add normal saline for injection or buffer for injection, or fat emulsion for injection to prepare 100ml finished product.
Embodiment 2
[0042] According to inactivated Salmonella typhi 500 million-15 billion, inactivated pertussis 1 billion-10 billion, diphtheria toxoid 0-2000Lf or tetanus toxoid 0-500Lf or Staphylococcus aureus enterotoxin C 0-5000ng , the ratio of polysaccharide 0-5g to prepare active ingredients, add normal saline for injection or buffer for injection, or fat emulsion for injection to prepare 50ml finished product.
Embodiment 3
[0044] According to inactivated Salmonella typhi 500 million-15 billion, inactivated pertussis 1 billion-10 billion, diphtheria toxoid 0-2000Lf or tetanus toxoid 0-500Lf or Staphylococcus aureus enterotoxin C 0-5000ng , The ratio of polysaccharide 0-5g to prepare active ingredients, add normal saline for injection or buffer for injection, or fat emulsion for injection to prepare 200 ml finished product.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 